English

SUMMONS TO THE EXTRAORDINARY GENERAL MEETING OF BIOHIT OYJ

Report this content 
BIOHIT OYJ        STOCK EXCHANGE RELEASE              4 OCT 2005


SUMMONS TO THE EXTRAORDINARY GENERAL MEETING OF BIOHIT OYJ

The shareholders of Biohit Oyj are invited to attend the
Extraordinary General Meeting of Biohit Oyj to be held on
Thursday, 27 October 2005 at 17:00 (5:00 pm) at Restaurant
Pörssi, address: Fabianinkatu 14, 00100 Helsinki.

Agenda

The agenda of the General Meeting includes a proposal by the
Board of Directors concerning the issue of a convertible bond to
be offered for subscription by a limited group of professional
investors.

It is proposed that the shareholders’ pre-emptive right to
subscription be deviated from, since the objective of the
transaction is to strengthen the Company’s growth potential and
broaden its investor base.

The maximum amount of the convertible bond will be EUR
4,050,000. The convertible bond will be issued within the
electronic book-entry system. The convertible bond will be
issued to a maximum number of 900 note units with a nominal
value of EUR 4,500. The annual fixed interest to be paid on the
convertible bond is 6.5 per cent. The convertible bond will have
a five year maturity.

Each EUR 4,500 note unit can be converted into 1,000 Biohit Oyj
B-shares with a nominal value of EUR 0.17. The conversion rate
is EUR 4.50. The conversion period will begin on the date when
the subscription of the convertible bond is entered into the
Trade Register and will end on 30 September 2010.

As a result of the conversion the share capital of the Company
may be increased by a maximum of EUR 153,000 and the number of B-
shares by a maximum of 900,000 new shares.

Documents

The proposals by the Board of Directors to the General
Meeting are available for review by shareholders as of 18
October 2005 at the Corporate Headquarters of Biohit,
address: Laippatie 1, 00880 Helsinki. Copies of the documents
will be submitted to shareholders upon request.

Right of Participation and Notification

Shareholders, who on 17 October 2005 at the latest have been
listed on the shareholder register of the Company, maintained
by the Finnish Central Securities Depository, have the right
to participate in the Meeting.

Shareholders who have not transferred their shares to the
book-entry securities system are also entitled to participate
in the General Meeting, provided that the shareholders have
been registered in the corporate register of shareholders
before 10 April 1995. In this case the shareholder is liable
to present proof that the right of ownership of his/her
shares has not been transferred to any book-entry securities
account.

Shareholders wishing to participate in the General Meeting
must notify the Company of their participation to the
Corporate Headquarters no later than 25 October 2005 by 12:00
(noon) either in writing to: Biohit Oyj, General Meeting,
Laippatie 1, FI-00880, Helsinki; by e-mail to:
yhtiokokous@biohit.com; by telefax to: +358-9-773 86 205; or
by telephone to: Sanna Kurlin +358-9-773 861 (switchboard).
Any powers of attorney must be submitted by mail before the
closing of the registration period.

Helsinki, 4 October 2005

Biohit Oyj
Board of Directors


Further information:   Osmo Suovaniemi, M.D., Ph.D., Professor
                       President & CEO
                       Tel: +358-9-773 861
                       Mobile: +358-40-745 5605
                       Email: osmo.suovaniemi@biohit.com
                       http://www.biohit.com
                       
Distribution:          Helsinki Exchanges
                       Financial Supervisory Authority
                       Press

Subscribe